Hello! This is July 22, 2025.

Nuclear Weapons Agency Breached in Microsoft Hack

The U.S. National Nuclear Security Administration was hit by a cyberattack exploiting Microsoft’s SharePoint software, according to Bloomberg. Officials say no classified material appears compromised, but the breach raises fresh concerns about cybersecurity in critical agencies. Investigations are ongoing as federal agencies remain silent on details.

Trump Seals Historic $550B Trade Deal With Japan

President Trump announced a record-breaking $550 billion trade deal with Japan that includes reciprocal tariffs and expanded market access for U.S. goods. The agreement is expected to create hundreds of thousands of American jobs and open Japan’s markets to cars, trucks, and agriculture. Trump hinted at additional trade deals with Europe and the Philippines in the coming days.

Feds Foil Manhattan Bomb Plot, Arrest NY Man

A New York man faces federal charges for allegedly building and stashing homemade bombs on subway tracks and rooftops across Manhattan. Michael Gann, 55, was arrested after authorities discovered at least seven improvised explosive devices. Officials say swift law enforcement action prevented a potential tragedy in the city.

Trump Floats Ending Capital Gains Tax on Home Sales

President Trump said his administration is considering eliminating capital gains taxes on home sales to spur the housing market. The move aligns with Rep. Marjorie Taylor Greene’s proposed No Tax on Home Sales Act, which she praised as a step toward financial fairness. Critics warn the measure could add to national debt while benefiting wealthier Americans.

Goldman Sachs Boosts Targets on 3 Dividend Blue Chips

Goldman Sachs raised price targets by over 10% on Citizens Financial, Delta Air Lines, and Eaton Corporation after strong earnings and positive inflation trends. Analysts see these stocks as prime picks for growth and income, citing dependable dividends and sector strength. The upgrades reflect optimism for the market’s second half of 2025.

Cancer Drug Combo Shows Promise in Reversing Alzheimer’s

Researchers discovered that combining two FDA-approved cancer drugs restored brain cells and improved memory in mice with Alzheimer’s. The drugs, letrozole and irinotecan, reversed gene disruptions linked to the disease and reduced toxic protein buildup. Early human data also suggests lower Alzheimer’s rates among cancer patients treated with these drugs, prompting calls for swift clinical trials.

Experimental Drug Erases Deadly Brain Tumor in Patient

A man diagnosed with aggressive glioblastoma shows no signs of cancer two years after receiving the immunotherapy drug ipilimumab. Doctors credit the treatment for boosting his immune system and halting tumor growth, a rare outcome in such cases. A new clinical trial hopes to replicate these promising results for more patients battling the deadly disease.